Signaling of High Mobility Group Box 1 (HMGB1) through Toll-like Receptor 4 in Macrophages Requires CD14

Overview of attention for article published in Molecular Medicine, March 2013

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#19 of 1,162)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 11 news outlets
twitter: 1 X user

patent: 7 patents

Citations

dimensions_citation: 144 Dimensions

Readers on

mendeley: 119 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

HMGB1 antagonist treatment of severe sepsis

Grant US-11883461-B2

United States of America

HMGB1 antagonist treatment of acute lung injury

Grant US-11684652-B2

United States of America

HMGB1 antagonist treatment of severe sepsis

Grant US-11524048-B2

United States of America

HMGB1 antagonist

Grant US-11471507-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 3 additional patents.